Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharmascience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmascience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmascience Inc Today - Breaking & Trending Today

Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer - Vimarsana News

Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer

Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.

Source: ndtv.com
Lupin bags USFDA tentative approval for Dasatinib Tablets; stock jumps ~2% - Vimarsana News

Lupin bags USFDA tentative approval for Dasatinib Tablets; stock jumps ~2%

Dasatinib Tablets (RLD Sprycel) has expected annual sales in the United States of USD 1,569 million, as per the IQVIA MAT June 2022.

A Pain Med Is Being Recalled Because Of An Error Officials Say Could Lead To An Overdose - Vimarsana News

A Pain Med Is Being Recalled Because Of An Error Officials Say Could Lead To An Overdose

A pain medication is subject to a recall in Canada because of a packaging error. The problem is that bottles from a lot of 2-milligram pms-Hydromorphone tablets from the company Pharmascience Inc. may include some stronger 8-milligram tablets.

Canada's new patent claim fee rules: Alternative embodiments within a single claim | Smart & Biggar - Vimarsana News

Canada's new patent claim fee rules: Alternative embodiments within a single claim | Smart & Biggar

Historically, claim fees have not been payable at any time during the pendency of a Canadian patent application or term of the patent. This will change soon, and the present article...

Pharmascience International is proud to enter the United States market with the launch of Bortezomib 3.5 mg/vial - Vimarsana News

Pharmascience International is proud to enter the United States market with the launch of Bortezomib 3.5 mg/vial

Pharmascience International is proud to enter the United States market with the launch of Bortezomib 3.5 mg/vial - read this article along with other careers information, tips and advice on BioSpace